TY  - JOUR
AU  - Doege, Daniela
AU  - Frick, Julien
AU  - Eckford, Rachel
AU  - Koch-Gallenkamp, Lena
AU  - Schlander, Michael
AU  - Arndt, Volker
TI  - Anxiety and depression in cancer patients and survivors in the context of restrictions in contact and oncological care during the COVID-19 pandemic.
JO  - International journal of cancer
VL  - 156
IS  - 4
SN  - 0020-7136
CY  - Bognor Regis
PB  - Wiley-Liss
M1  - DKFZ-2024-01992
SP  - 711-722
PY  - 2025
N1  - #EA:C070#EA:C071#EA:M110#LA:C070#LA:C071#LA:M110# / 2025 Feb 15;156(4):711-722
AB  - Treatment modifications and contact restrictions were common during the COVID-19 pandemic and can be stressors for mental health. There is a lack of studies assessing pandemic-related risk factors for anxiety and depression of cancer patients and survivors systematically in multifactorial models. A total of 2391 participants, mean age 65.5 years, ≤5 years post-diagnosis of either lung, prostate, breast, colorectal cancer, or leukemia/lymphoma, were recruited in 2021 via the Baden-Württemberg Cancer Registry, Germany. Sociodemographic information, pandemic-related treatment modifications, contact restrictions, and anxiety/depression (Hospital Anxiety and Depression Scale, HADS) were assessed via self-administered questionnaire. Clinical information (diagnosis, stage, and treatment information) was obtained from the cancer registry. Overall, 22
KW  - SARS‐CoV‐2 (Other)
KW  - cancer registry (Other)
KW  - mental health (Other)
KW  - social contact (Other)
KW  - treatment modifications (Other)
KW  - well‐being (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:39361297
DO  - DOI:10.1002/ijc.35204
UR  - https://inrepo02.dkfz.de/record/293862
ER  -